-
Renji Hospital Partners with Raffles Medical Group to Boost Shanghai’s Medical Tourism
•
Renji Hospital, a comprehensive Class 3A hospital established in 1844 in Shanghai, has partnered with Singapore’s Raffles Medical Group. The collaboration aims to establish a “dual circulation” service system for medical resources and promote a new model of coordinated development between public hospitals and international medical groups. This initiative is…
-
NHC Data Reveals Digital Leap for Class 3 Hospitals Amid Drug Cost Crackdown
•
China’s 2,168 Class 3 public hospitals demonstrated enhanced fiscal discipline in 2023, with medical services revenue rising 0.94 pp to 29.59%. Key cost-control measures drove reductions in auxiliary medication (-0.03 pp to 0.62%) and high-value consumables (-3.22 pp to 24.86%). Essential drug utilization improved, with inpatient adoption reaching 96.30% (+0.13…
-
China Resources Medical Holdings Reports 2024 Revenue of RMB9.86 Billion Amid Net Profit Surge
•
China Resources Medical Holdings Company Ltd (CR Medical, HKG: 1515) has published its 2024 financial report. The company recorded revenues of RMB 9.86 billion (USD 1.4 billion), marking a 2.5% year-on-year (YOY) decrease. Despite the revenue decline, net profits rose significantly by 104.9% YOY to RMB 672 million (USD 92.5…
-
Distinct Healthcare Files for Hong Kong IPO to Expand Integrated Medical Services
•
Shenzhen-based Distinct Healthcare Holdings Limited, a comprehensive medical service provider with integrated online and offline offerings, has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange. This move marks a significant step in the company’s growth strategy and capital market expansion. Company OverviewSince its inception in…
-
Shanghai Fosun Pharmaceutical Transfers Unicorn II Holdings Stake to Warburg Pincus Subsidiary
•
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) announced plans to transfer its entire stake of 9.4 million shares in Unicorn II Holdings Limited to Calcite Gem, a subsidiary of Warburg Pincus. The transaction, valued at USD13.2 per share, totals USD124 million. Upon completion, Fosun will no…
-
Basecare and Rhea Labs Form Five-Year Alliance to Expand IVF Markets Globally
•
China-based IVF specialist Suzhou Basecare Medical Co., Ltd (HKG: 2170) has entered into a five-year strategic alliance with Singapore’s Rhea Labs Pte. Ltd to jointly expand in vitro fertilization (IVF) markets globally. The partnership aims to leverage both companies’ commercial strengths in the US, Europe, South America, and Southeast Asia,…
-
Hainan Boao Lecheng Pilot Zone Implements Baclofen Intrathecal Therapy
•
The Hainan Boao Lecheng Pilot Zone Management Bureau announced the implementation of Baclofen Intrathecal Sintetica, a special treatment for severe spasms, at the Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine and Hainan Boao Research Hospital. This therapy is suitable for patients with severe spinal cord-derived chronic spasticity (related…
-
Douyin Gains Approval to Establish Hospital in Beijing’s Zhongguancun
•
The Beijing Municipal Health Commission has approved Douyin, the Chinese short-form video hosting service owned by ByteDance, to establish a hospital in Zhongguancun, Chaoyang District. This marks a significant expansion for Douyin, known internationally as TikTok, into the healthcare sector. Hospital DetailsThe planned hospital will be a Class 3 comprehensive…
-
Beijing Releases List of Novel Drugs and Technologies Exempt from CHS-DRG Payment Scheme
•
The Beijing Municipal Medical Insurance Bureau has released the list of the first batch of novel drugs and technologies that will enjoy payment outside of the China Health-care Security Diagnosis Related Groups (CHS-DRG) payment scheme. A total of 24 payment items are included, featuring small molecule inhibitors such as olaparib,…
-
Perennial Real Estate Holdings’ Tianjin Hospital Earns Medical Practice License
•
Singapore-based Perennial Real Estate Holdings Limited has announced that its Perennial General Hospital in Tianjin has received the Practice License of Medical Institution from the city’s health commission bureau. This milestone makes the hospital the first wholly foreign-owned Class III comprehensive hospital in China. Tianjin Perennial Hospital’s Strategic Location and…
-
China’s Health Commission Issues Guidelines to Strengthen Ties Between Healthcare and Elderly Care
•
The National Health Commission, in conjunction with three other bureaus, has issued the “Notice on Deepening Collaboration Agreements Between Medical/Health Institutions and Elderly Care Institutions.” This document outlines the requirements for cooperation between medical and health institutions and elderly care institutions, focusing on content, safety, mechanisms, and modes of collaboration.…
-
Abogen Biosciences and Ruijin Hospital Launch Ruijin Abogen Nucleic Acid Drug Research Institute
•
China-based nucleic acid drug developer Suzhou Abogen Biosciences and Ruijin Hospital, a comprehensive Class 3A hospital in Shanghai, have jointly announced the establishment of the Ruijin Abogen Nucleic Acid Drug Research Institute. The new institute aims to further explore the application of mRNA drugs in tumors and autoimmune diseases, with…
-
Beijing Expands Medical Insurance Coverage to Include Anti-Aquaporin Antibody Testing and Advanced Heart Procedures
•
The Beijing Municipal Medical Insurance Bureau and the Beijing Municipal Human Resources and Social Security Bureau have issued a notification to include new medical service items such as anti-aquaporin antibody testing in the medical insurance coverage, with a focus on dynamically adjusting their prices. The update extends coverage to include…
-
Innovent Biologics Launches Phase I Clinical Trial for IBR822 Cell Injection Solution in Solid Tumors
•
Innovent Biologics (Hangzhou) Co., Ltd (HKG: 1801, OTCMKTS: IVBXF), a biopharmaceutical company based in China, has announced the successful initiation of a Phase I clinical trial for its proprietary IBR822 cell injection solution at Zhejiang Cancer Hospital. The trial, led by Professor Song Zhengbo from Zhejiang Cancer Hospital, is conducted…
-
Former Hainan Medical University President Li Jingquan Expelled for Serious Disciplinary Violations
•
Hainan’s disciplinary inspection committee has announced the expulsion of Li Jingquan, the former president of the First Affiliated Hospital of Hainan Medical University, from the Communist Party and public office due to serious violations of discipline and law. Li was found to have committed multiple infractions, including accepting gifts and…
-
Hygeia Healthcare Holdings Acquires Chang An Hospital in Deal Valued at RMB 1.66 Billion
•
Hygeia Healthcare Holdings Co., Ltd, a Shanghai-based medical investment and healthcare group, has announced the completion of an acquisition, securing a 100% stake in Chang An Hospital, a state-owned Class 3A general hospital. The transaction, which is reported to have already been finalized, involved a consideration of approximately RMB 1.66…
-
WeDoctor Partners with Shanghai Children’s Medical Center to Enhance Pediatric Care
•
WeDoctor Holdings Ltd, a subsidiary of Chinese internet conglomerate Tencent Corporate Venture Capital (HKG: 0700) that specializes in online medical services, has entered into a strategic partnership with Shanghai Children’s Medical Center. While financial details of the agreement were not disclosed, the collaboration aims to combine WeDoctor’s expertise in digitalization…
-
China Issues Ethical Guidelines for Human Genome Editing, Prohibits Germline Editing
•
China’s Ministry of Science and Technology (MOST) has issued the Ethical Guidelines for Human Genome Editing Research, establishing a framework to regulate such activities and ensure their responsible development. The guidelines place a stringent prohibition on germline editing, which involves genetic modifications that could be passed down to future generations.…
-
Shineco Inc. Acquires 80% Stake in ‘Internet+Medical Care’ Platform Meitong Tech for USD 20 Million
•
Shineco Inc. (NASDAQ: SISI), a U.S.-based company, has signed an investment agreement with Beijing Dongfang Meitong Technology Co., Ltd, a China-headquartered “Internet+medical care” platform. Shineco is set to acquire an 80% stake in Meitong Tech for USD 20 million. Meitong Tech, a leading shared medical device company in China, offers…
-
China’s NHC Mandates Urban Hospitals to Aid County-Level Medical Institutions
•
The National Health Commission (NHC) has issued a notification aimed at further promoting the allocation of urban medical resources to county hospitals and grassroots medical institutions. The directive emphasizes that urban Class 3 hospitals should provide assistance to county hospitals, particularly those with underperforming metrics. The notice outlines several key…
